In this article, we identify the top 10 most impactful articles for pediatric hospital medicine in 2025, as presented at the ...

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

A startling new vision of vaccination in America is becoming clearer — one likely to involve fresh scrutiny of established science and practices, and limits on vaccines that have been studied for ...

The CDC's Advisory Committee on Immunization Practices (ACIP) has issued new vaccine recommendations affecting RSV and flu ...

Taking aim at a longtime target of anti-vaccine activists, CDC advisors said Thursday that the U.S. should not administer ...

An advisory panel recently appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to walk back long-standing recommendations for flu vaccines containing an ingredient that the anti-vaccine ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

The meeting included a discussion of thimerosal, a mercury-based preservative and longtime target of the anti-vaccine world.

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient treatment and parental work absences in Europe ...

The study included 11,681 RSV-associated hospitalizations from 2018 to 2020 and 6708 from 2024 to 2025. The median age of the children with RSV-associated hospitalizations was significantly older ...